Cooper Jared B, Ronecker Jennifer S, Tobias Michael E, Mohan Avinash L, Hillard Virany, Murali Raj, Gandhi Chirag D, Schmidt Meic H, Jhanwar-Uniyal Meena
Department of Neurosurgery, WMCH/New York Medical College, Valhalla, NY, U.S.A.
Anticancer Res. 2018 Apr;38(4):1859-1877. doi: 10.21873/anticanres.12424.
Brain metastases are the leading cause of morbidity and mortality among cancer patients, and are reported to occur in about 40% of cancer patients with metastatic disease in the United States of America. Primary tumor cells appear to detach from the parent tumor site, migrate, survive and pass through the blood brain barrier in order to establish cerebral metastases. This complex process involves distinct molecular and genetic mechanisms that mediate metastasis from these primary organs to the brain. Furthermore, an interaction between the invading cells and cerebral milieu is shown to promote this process as well. Here, we review the mechanisms by which primary cancer cells metastasize to the brain via a mechanism called epithelial-to-mesenchymal transition, as well as the involvement of certain microRNA and genetic aberrations implicated in cerebral metastases from the lung, breast, skin, kidney and colon. While the mechanisms governing the development of brain metastases remain a major hindrance in treatment, understanding and identification of the aforementioned molecular pathways may allow for improved management and discovery of novel therapeutic targets.
脑转移是癌症患者发病和死亡的主要原因,据报道,在美国约40%的转移性疾病癌症患者中会发生脑转移。原发性肿瘤细胞似乎从原发肿瘤部位脱离,迁移、存活并穿过血脑屏障,从而形成脑转移瘤。这个复杂的过程涉及不同的分子和遗传机制,这些机制介导了从这些原发器官到脑的转移。此外,侵袭细胞与脑内环境之间的相互作用也被证明会促进这一过程。在这里,我们回顾了原发性癌细胞通过一种称为上皮-间质转化的机制转移到脑的机制,以及某些微小RNA和基因畸变在肺、乳腺、皮肤、肾和结肠脑转移中的作用。虽然控制脑转移发生发展的机制仍然是治疗的主要障碍,但对上述分子途径的理解和识别可能有助于改善治疗管理并发现新的治疗靶点。